Congress Asset Management Co. MA acquired a new position in Simulations Plus, Inc. (NASDAQ:SLP) during the third quarter, according to its most recent filing with the SEC. The firm acquired 73,722 shares of the technology company’s stock, valued at approximately $2,558,000.
Several other hedge funds have also modified their holdings of the company. Neuburgh Advisers LLC raised its holdings in Simulations Plus by 419.4% during the second quarter. Neuburgh Advisers LLC now owns 2,576 shares of the technology company’s stock worth $74,000 after purchasing an additional 2,080 shares in the last quarter. Glen Harbor Capital Management LLC increased its holdings in Simulations Plus by 419.4% in the second quarter. Glen Harbor Capital Management LLC now owns 3,542 shares of the technology company’s stock valued at $101,000 after buying an additional 2,860 shares in the last quarter. Elkfork Partners LLC increased its holdings in Simulations Plus by 419.4% in the second quarter. Elkfork Partners LLC now owns 4,508 shares of the technology company’s stock valued at $129,000 after buying an additional 3,640 shares in the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Simulations Plus by 5.9% in the second quarter. Oppenheimer Asset Management Inc. now owns 4,783 shares of the technology company’s stock valued at $137,000 after buying an additional 265 shares in the last quarter. Finally, Meadow Creek Investment Management LLC increased its holdings in Simulations Plus by 419.4% in the second quarter. Meadow Creek Investment Management LLC now owns 5,474 shares of the technology company’s stock valued at $156,000 after buying an additional 4,420 shares in the last quarter. Hedge funds and other institutional investors own 41.35% of the company’s stock.
In related news, Director Walter S. Woltosz sold 24,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 24th. The shares were sold at an average price of $35.86, for a total transaction of $860,640.00. Following the sale, the director now owns 5,087,918 shares in the company, valued at $182,452,739.48. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold 72,000 shares of company stock worth $2,532,720 over the last quarter. Company insiders own 31.57% of the company’s stock.
Shares of SLP stock traded up $0.27 during trading hours on Friday, hitting $33.25. The company’s stock had a trading volume of 100,300 shares, compared to its average volume of 92,136. The business has a fifty day moving average of $34.58 and a 200-day moving average of $31.43. The stock has a market cap of $592.56 million, a price-to-earnings ratio of 66.50 and a beta of -0.34. Simulations Plus, Inc. has a twelve month low of $17.18 and a twelve month high of $41.95.
The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Friday, October 25th were given a $0.06 dividend. The ex-dividend date of this dividend was Thursday, October 24th. This represents a $0.24 annualized dividend and a dividend yield of 0.72%. Simulations Plus’s dividend payout ratio is presently 48.00%.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Read More: Momentum Indicators
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.